Biomarker levels of p-tau181 and t-tau correlated strongly in controls, AD, and FTLD groups (controls, ρ = 0.701; AD, ρ = 0.887; FTLD, ρ = 0.769; all p < 0.001). Here, MAPT is linked to Alzheimer disease.